MiR-29a modulates the angiogenic properties of human endothelial cells

Biochemical and Biophysical Research Communications

Volumn 434, Issue 1, 2013, Pages 143-149

  Yang, Zeran ^a   Wu, Lingjiao ^b   Zhu, Xiuming ^c   Xu, Jie ^d   Jin, Rong ^e   Li, Guohong ^e   Wu, Fusheng ^f  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d Anqing Municipal Hospital   (China)

^e LOUISIANA STATE UNIVERSITY   (United States)

^f ZHEJIANG UNIVERSITY   (China)

Author keywords

Angiogenesis; Endothelial cell; HBP1; Hypoxia; MiRNA 29a

Indexed keywords

HMG BOX CONTAINING PROTEIN 1; LUCIFERASE; MICRORNA 29A; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANGIOGENESIS; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

BASE SEQUENCE; CELL HYPOXIA; ENDOTHELIUM, VASCULAR; HIGH MOBILITY GROUP PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRESSOR PROTEINS;

EID: 84876806089     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.054     Document Type: Article

References (21)

1. Ivan M., Harris A.L., Martelli F., Kulshreshtha R. Hypoxia response and microRNAs: no longer two separate worlds. Cell Mol. Med. 2008, 12 (5A):1426-1431.
2. Shi H., Chen L., Wang H., Zhu S., Dong C., et al. Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes. Biophys. Res. Commun. 2013, 430:827-832.
3. Wu F., Yang Z., Li G. Role of specific microRNAs for endothelial function and angiogenesis. Biophys. Res. Commun. 2009, 386:549-553.
4. Pekarsky Y., Croce C.M. Is miR-29 an oncogene or tumor suppressor in CLL?. Oncotarget 2010, 1:224-227.
5. Cui Y., Su W.Y., Xing J., Wang Y.C., Wang P., et al. MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One 2011, 6:e25872.
6. Teichler S., Illmer T., Roemhild J., Ovcharenko D., Stiewe T., et al. MicroRNA29a regulates the expression of the nuclear oncogene Ski. Blood 2011, 118:1899-1902.
7. Kong G., Zhang J., Zhang S., Shan C., Ye L., et al. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One 2011, 6:e19518.
8. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006, 108:3068-3071.
9. Zile M.R., Mehurg S.M., Arroyo J.E., Stroud R.E., DeSantis S.M., et al. Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction. Circ. Cardiovasc. Genet. 2011, 4:614-619.
10. Paulson K.E., Rieger-Christ K., McDevitt M.A., Kuperwasser C., Kim J., et al. Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer. Cancer Res. 2007, 67:6136-6145.
11. Shilo S., Roy S., Khanna S., Sen C.K. Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28:471-477.
12. Yang Z., Li J.C. Stimulation of endothelin-1 gene expression by insulin via phosphoinositide-3 kinase-glycogen synthase kinase-3beta signaling in endothelial cells. Life Sci. 2008, 82:512-518.
13. Kuehbacher A., Urbich C., Zeiher A.M., Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 2007, 101:59-68.
14. Nagasawa H. Pathophysiological response to hypoxia-from the molecular mechanisms of malady to drug discovery: drug discovery for targeting the tumor microenvironment. J. Pharmacol. Sci. 2011, 115:446-452.
15. Fasanaro P., D'Alessandra Y., Di Stefano V., Melchionna R., Romani S., et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 2008, 283:15878-15883.
16. Han Y.C., Park C.Y., Bhagat G., Zhang J., Wang Y., et al. MicroRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J. Exp. Med. 2010, 207:475-489.
17. Gebeshuber C.A., Zatloukal K., Martinez J. MiR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 2009, 10:400-405.
18. Santanam U., Zanesi N., Efanov A., Costinean S., Palamarchuk A., et al. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc. Nat. Acad. Sci. U.S.A. 2010, 107:12210-12215.
19. Kapinas K., Kessler C., Ricks T., Gronowicz G., Delany A.M. MiR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J. Biol. Chem. 2010, 285:25221-25231.
20. Escamilla-Powers J.R., Daniel C.J., Farrell A., Taylor K., Zhang X., et al. The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity. J. Biol. Chem. 2009, 285:4847-4858.
21. Wang L.G., Gu J. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol. 2011, 36:e61-e67.